News

January 2012


• SYNAGEVA BIOPHARMA ANNOUNCES CLOSING OF PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION

• SYNAGEVA BIOPHARMA ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

• Sandford D. Smith Joins Tullis Health Investors As Managing Director

December 2011


• Estech Announces Start of Patient Enrollment in HISTORIC-AF European Multi-center Staged Hybrid Ablation Study